Table 2 Comparison of clinical outcomes between the transfer group (TG) and direct admit group (DAG)
TG N = 68 | DAG N = 66 | P-value | |
|---|---|---|---|
Hours from ED presentation to surgery | < 0.0001 | ||
0 to 6 | 65 (95.6%) | 7 (10.6%) | |
6.1 to 12 | 1 (1.5%) | 34 (51.5%) | |
12.1–18 | 1 (1.5%) | 11 (16.7%) | |
> 18 | 1 (1.5%) | 14 (21.2%) | |
Site of infection | 0.0499* | ||
Abdominal wall and chest | 3 (4.4%) | 5 (7.6%) | |
Perineum and buttock | 15 (22.1%) | 9 (13.6%) | |
Upper extremity | 17 (25%) | 30 (45.5%) | |
Lower extremity | 33 (48.5%) | 22 (33.3%) | |
Intravenous/subcutaneous drug injection | 21 (30.9%) | 20 (30.3%) | 0.9420 |
Diabetes mellitus | 42 (61.8%) | 37 (56.1%) | 0.5022 |
End stage renal disease (dialysis) | 3 (4.4%) | 10 (15.2%) | 0.0357 |
Hypertension | 27 (39.7%) | 32 (48.5%) | 0.3061 |
Dead at hospital discharge | 8 (11.8%) | 15 (22.7%) | 0.0925 |
Extremity amputation | 13 (19.1%) | 11 (16.7%) | 0.7114 |
Skin graft | 22 (32.4%) | 16 (24.2%) | 0.2977 |